Skip to main content

Table 1 Distribution of various atherosclerotic risk factors and inflammation markers, specified by steatohepatitis, fatty liver and normal control groups

From: Interaction of obesity, metabolic syndrome and Framingham risk on steatohepatitis among healthy Taiwanese: population-based nested case-control study

    Steatohepatitis N = 124    Fatty liver only N = 124    Normal N = 124 P value*
Mean Std median   Q1   Q3   Mean Std median   Q1   Q3   Mean Std median   Q1   Q3   
Age (years) 49.7 ± 11.0 49 ( 42 - 57 ) 49.8 ± 10.6 49 ( 43 - 57 ) 49.5 ± 11.9 49 ( 43 - 57 ) 0.970
Weight (kg) 77.0 ± 11.4 75 ( 70 - 83 ) 71.5 ± 10.0 72 ( 65 - 78 ) 65.0 ± 9.5 65 ( 58 - 72 ) <.0001
BMI (kg/m2) 27.6 ± 3.1 27 ( 25 - 29 ) 25.5 ± 2.7 26 ( 24 - 27 ) 23.4 ± 2.7 23 ( 22 - 25 ) <.0001
Fasting glucose (mg/dL) 107.9 ± 29.5 98 ( 89 - 117 ) 100.1 ± 27.3 92 ( 87 - 101 ) 92.9 ± 20.8 89 ( 84 - 95 ) <.0001
HDL-cholesterol (mg/dL) 42.4 ± 9.2 41 ( 36 - 48 ) 44.9 ± 10.9 43 ( 38 - 49 ) 50.9 ± 11.9 50 ( 43 - 58 ) <.0001
Triglyceride (mg/dL) 195.9 ± 89.5 176 ( 130 - 256 ) 166.6 ± 86.0 146 ( 115 - 201 ) 107.4 ± 51.7 96 ( 70 - 136 ) <.0001
Systolic blood pressure (mmHg)** 127.9 ± 13.9 126 ( 119 - 137 ) 124.5 ± 15.0 123 ( 116 - 128 ) 120.8 ± 13.6 120 ( 110 - 128 ) <.0001
Diastolic blood pressure (mmHg)** 80.7 ± 9.8 80 ( 74 - 87 ) 77.4 ± 11.7 78 ( 71 - 83 ) 74.0 ± 11.8 73 ( 68 - 82 ) <.0001
Total cholesterol (mg/dL) 202.4 ± 36.0 204 ( 183 - 229 ) 200.3 ± 33.1 197 ( 181 - 217 ) 184.4 ± 35.1 182 ( 159 - 206 ) <.0001
LDL-cholesterol (mg/dL) 121.3 ± 30.9 119 ( 102 - 143 ) 122.1 ± 32.2 119 ( 105 - 136 ) 106.9 ± 29.8 101 ( 84 - 125 ) <.0001
White Blood Cell (/μL) 6920 ± 1525 6745 ( 5920 - 7960 ) 6780 ± 1685 6555 ( 5665 - 7685 ) 6471 ± 1563 6195 ( 5360 - 7900 ) 0.071
Lymphocyte (/μL) 2488 ± 693 2442 ( 2065 - 2843 ) 2384 ± 660 2238 ( 1943 - 2753 ) 2233 ± 765 2109 ( 1674 - 2691 ) 0.002
Neutrophils (/μL) 3656 ± 1134 3557 ( 2898 - 4445 ) 3621 ± 1208 3420 ( 2671 - 4186 ) 3481 ± 1096 3268 ( 2658 - 4183 ) 0.371
C-reactive protein (mg/dL) 0.33 ± 0.39 0.24 ( 0.14 - 0.37 ) 0.26 ± 0.27 0.17 ( 0.05 - 0.31 ) 0.21 ± 0.32 0.14 ( 0.05 - 0.25 ) <.0001
Framingham score 10.9 ± 5.1 11 ( 8 - 15 ) 9.6 ± 5.1 10 ( 7 - 13 ) 8.5 ± 5.8 10 ( 7 - 12 ) 0.006
Framingham risk 9.4 ± 8.6 6 ( 3 - 12 ) 7.4 ± 7.2 5 ( 2 - 10 ) 6.3 ± 6.2 4.5 ( 1 - 8 ) 0.009
Smoking amount (pack*year) 9.7 ± 18.0 0 ( 0 - 16 ) 5.9 ± 20.2 0 ( 0 - 3 ) 8.2 ± 15.6 0 ( 0 - 12.5 ) 0.043
HbA1c (%) 5.9 ± 1.2 5.6 ( 5.2 - 6.1 ) 5.6 ± 0.9 5.4 ( 5.1 - 5.8 ) 5.3 ± 0.7 5.1 ( 5.0 - 5.4 ) <.0001
  1. *Significance test was by nonparametric Kruskal-Wallis test, Q1: 25th percentile, Q3: 75th percentile, Std: standard deviation